CoGenesys
Series A in 2006
CoGenesys is a biopharmaceutical company dedicated to the development of peptide- and protein-based medicines. The company focuses on creating therapeutics for a range of diseases, including cancer, cardiovascular, metabolic, infectious, autoimmune, and central nervous system disorders. CoGenesys conducts clinical trials to demonstrate the safety and efficacy of its bio-therapeutics, and subsequently seeks to license or partner its compounds to secure funding for continued development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.